- Zerenia™ expansion follows successful start to 2021, with paid
prescriptions in first 2.5 months of the year exceeding total 2020
prescriptions in Colombia
- Satellite clinics proving an effective patient acquisition
model; in first two months of 2021, a significant number of new
paying patients were acquired through Khiron's satellite
clinics
- Khiron recently opened two additional satellite Zerenia™
clinics in major metropolitan centres of Cali and Bucaramanga in Colombia (over 2.5 million population
combined), bringing the Company's total health centre and clinic
count to six
- As the Company expands its vertical integration model, it plans
to open additional satellite clinics in Colombia over the course of the year, in
addition to the previously announced clinic strategy in
Mexico
TORONTO, March 18, 2021 /CNW/ - Khiron Life Sciences Corp.
("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF)
(Frankfurt: A2JMZC), a vertically
integrated cannabis leader with core operations in Latin America and Europe, today announces that it has opened two
additional satellite Zerenia™ clinics in Colombia following the success of its initial
small format clinic in Medellin.
In line with the Company's stated strategy, the new satellite
clinics in Cali and Bucaramanga
opened their doors to patients in early March, 2021. The satellite
clinics are located in high-traffic, medical-hub neighbourhoods and
are supported by Khiron's flagship health centres in
Bogota.
The new Zerenia™ locations expand Khiron's clinic
network to six, improving access to the Company's clinic services
and medical cannabis products for patients across the country.
Patients in Cali and Bucaramanga
may now connect with medical specialists trained in the ethical,
safe, and responsible prescription of cannabis-based medications in
person or through Khiron's Doctor Zerenia™
telemedicine platform.
"We are off to a great start in 2021 and the Zerenia satellite
clinic model is proving to be an exceptional platform for reaching
new patients. The rapid expansion of clinics is helping Khiron
reach more patients in more places, more conveniently, in these
cities. With the opening of two new satellite clinics in
Cali and Bucaramanga, Khiron has
taken another step toward increasing patient access to medical
cannabis, with the objective of improving the quality of life for
thousands of people in Colombia.
Our unique and proven business model will support our goal of
reaching 1,000,000 patients by 2024 in a sustainable manner,"
comments Alvaro Torres, Khiron CEO
and Director.
Based on positive physician and patient feedback at Khiron's
initial satellite clinics, the Company now plans to expand its
clinic presence in major metropolitan centres throughout
Colombia. Three additional
satellite Zerenia™ clinics, which will focus on treating
pathologies such as chronic pain, anxiety, insomnia, depression,
headache, epilepsy, and Parkinson's Disease, are expected to open
over the course of the year.
About Khiron Life Sciences Corp.
Khiron is a
vertically integrated medical and CPG cannabis company with core
operations in Latin America, and
operational activity in Europe and
North America. Khiron is the
leading medical cannabis provider in Colombia and the first company licensed in
Colombia for the cultivation,
production, domestic distribution and sales, and international
export of both low and high THC medical cannabis products. The
Company has filled medical cannabis prescriptions in Colombia, Peru and the UK, and is positioned to commence
sales of medical cannabis in Germany and Brazil in early 2021.
Leveraging wholly-owned medical clinics and proprietary
telemedicine platforms, Khiron combines a patient-oriented
approach, physician education programs, scientific expertise,
product innovation, and agricultural infrastructure to drive
prescriptions and brand loyalty. Its Wellbeing unit launched the
first branded CBD skincare brand in Colombia, with KuidaTM now marketed
in multiple jurisdictions in Latin
America, the US and UK. The Company is led by Co-founder and
Chief Executive Officer, Alvaro
Torres, together with an experienced and diverse executive
team and Board of Directors.
Visit Khiron online at investors.khiron.ca and on Instagram
@khironlife.
Cautionary Notes
Forward-Looking Statements
This press release may contain certain "forward-looking
information" and "forward-looking statements" within the meaning of
applicable securities legislation. All information contained herein
that is not historical in nature may constitute forward-looking
information. Khiron undertakes no obligation to comment on
analyses, expectations or statements made by third-parties in
respect of Khiron, its securities, or financial or operating
results (as applicable). Although Khiron believes that the
expectations reflected in forward-looking statements in this press
release are reasonable, such forward-looking statement has been
based on expectations, factors and assumptions concerning future
events which may prove to be inaccurate and are subject to numerous
risks and uncertainties, certain of which are beyond Khiron's
control, including the risk factors discussed in Khiron's Annual
Information Form which is available on Khiron's SEDAR profile at
www.sedar.com. The forward-looking information contained in this
press release is expressly qualified by this cautionary statement
and is made as of the date hereof. Khiron disclaims any intention
and has no obligation or responsibility, except as required by law,
to update or revise any forward-looking information, whether as a
result of new information, future events or otherwise.
Neither the TSXV nor its Regulation Services Provider (as that
term is defined in the policies of the TSXV) accepts responsibility
for the adequacy or accuracy of this press release.
Investor Contact:
Paola Ricardo
E: investors@khiron.ca
T: +1 (833) 275-8984
Media Contact:
Elsa
Navarro
Vice President, Communications
E: enavarro@khiron.ca enavarro@khiron.ca
Khiron Europe:
Tejinder
Virk
Europe President
E: tvirk@khiron.ca
View original content to download
multimedia:http://www.prnewswire.com/news-releases/khiron-updates-zerenia-expansion-program-announces-plans-to-open-three-additional-satellite-clinics-in-colombia-by-end-of-q2-301249942.html
SOURCE Khiron Life Sciences Corp.